跳至主要内容
临床试验/IRCT20200111046084N1
IRCT20200111046084N1已完成2 期

Efficacy and safety of rivaroxaban versus enoxaparin on treatment of radial artery thrombosis after coronary arteries angiography

Rajaie Cardiovascular Medical and Research Center0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Provision of signed and dated informed consent form
  • All the patients that diagnosed with radial artery thrombosis after coronary angiography
  • Men and Women
  • being at the age of 18 years old or over

排除标准

  • Patients undergoing percutaneous coronary intervention
  • A condition associated with a high risk of bleeding
  • Severe renal dysfunction (creatinine clearance <30 mL/min)
  • Being allergic to rivaroxaban/enoxaparin

研究者

发起方
Rajaie Cardiovascular Medical and Research Center

相似试验